Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Central Nervous System Tumor
  • Ewing Sarcoma Family of Tumors
  • Leukemia
  • Neuroblastoma
  • Osteosarcoma
  • Rhabdomyosarcoma
Type
Interventional
Phase
Not Applicable
Design
Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Other

Participation Requirements

Age
Between 1 years and 25 years
Gender
Both males and females

Description

To identify and characterise: meaningful molecular genetic alterations, meaningful immunological features of high risk childhood, adolescents and young adult cancers, at diagnosis, during patient treatment and follow-up (time dimension).

To identify and characterise: meaningful molecular genetic alterations, meaningful immunological features of high risk childhood, adolescents and young adult cancers, at diagnosis, during patient treatment and follow-up (time dimension).

Tracking Information

NCT #
NCT03496402
Collaborators
Not Provided
Investigators
Principal Investigator: Gudrun SCHLEIERMACHER, MD Institut Curie